Issue Date	Title	Author(s)
1-Oct-2022	Comparison of immunogenicity and clinical effectiveness between BNT162b2 and ChAdOx1 SARS-CoV-2 vaccines in people with end-stage kidney disease receiving haemodialysis: a prospective, observational cohort study	Martin, P; Gleeson, S; Clarke, C; Thomson, T; Edwards, H, et al
7-Jun-2021	Comparison of two targeted ultra-deep sequencing technologies for analysis of plasma circulating tumour DNA in endocrine-therapy-resistant breast cancer patients	Nteliopoulos, G; Page, K; Hills, A; Howarth, K; Emmett, W, et al
Jun-2022	Comparison of vaccine effectiveness against the Omicron (B.1.1.529) variant in haemodialysis patients	Spensley, K; Gleeson, S; Martin, P; Thomson, T; Clarke, C, et al
11-Aug-2021	Complement activation in IgA nephropathy	Medjeral-Thomas, NR; Cook, HT; Pickering, MC;
1-Feb-2021	Complement activity is regulated in C3 glomerulopathy by IgG-factor H fusion proteins with and without properdin targeting domains	Gilmore, AC; Zhang, Y; Cook, HT; Lavin, DP; Katti, S, et al
28-Dec-2019	Complement factor H contributes to mortality in humans and mice with bacterial meningitis	Kasanmoentalib, ES; Seron, MV; Engelen-Lee, JY; Tanck, MW; Pouw, RB, et al
21-Feb-2017	Complement factor H inhibits CD47-mediated resolution of inflammation	Calippe, B; Augustin, S; Beguier, F; Charles-Messance, H; Poupel, L, et al
11-Jul-2019	Complement factor H modulates splenic B cell development and limits autoantibody production	Kiss, MG; Ozsvar-Kozma, M; Porsch, F; Goderle, L; Papac-Milicevic, N, et al
2-Sep-2019	Complete remission with incomplete count recovery (CRi) prior to allogeneic HCT for acute myeloid leukaemia is associated with a high non-relapse mortality.	Innes, A; Wooley, P; Szydlo, R; Lozano, S; Fernando, F, et al
1-Oct-2018	Conducting metagenomic studies in microbiology and clinical research	Martin, TC; Visconti, A; Spector, TD; Falchi, M
24-Feb-2018	Contemporary outcomes from the use of regular imaging to detect relapse in high-risk cutaneous melanoma	Lim, KHJ; Spain, L; Barker, C; Georgiou, A; Walls, G, et al
17-Sep-2001	Continual low-level activation of the classical complement pathway	Manderson, AP; Pickering, MC; Botto, M; Walport, MJ; Parish, CR
19-May-2020	Convalescent donor SARS-COV-2-specific cytotoxic T lymphocyte infusion as a possible treatment option for COVID-19 patients with severe disease has not received enough attention till date.	Hanley, B; Roufosse, CA; Osborn, M; Naresh, KN
6-Jan-2024	Correction: Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19	Matuozzo, D; Talouarn, E; Marchal, A; Zhang, P; Manry, J, et al
1-Jul-2015	Correlation of disease activity in proliferative glomerulonephritis with glomerular spleen tyrosine kinase expression	McAdoo, SP; Bhangal, G; Page, T; Cook, HT; Pusey, CD, et al
19-Jan-2017	Corrigendum: WNK1 kinase balances T cell adhesion versus migration in vivo	Köchl, R; Thelen, F; Vanes, L; Brazão, TF; Fountain, K, et al
12-Feb-2024	Could sex-specific subtypes of hand osteoarthritis exist? A retrospective study in women presenting to secondary care	Gulati, M; Brewer, G; Judge, A; Kennedy, D; Vincent, TL, et al
1-Mar-2022	COVID-19 in patients with glomerular disease.	Turner-Stokes, T; Edwards, H; Lightstone, L
Jun-2021	COVID-19 reinfection in a patient receiving immunosuppressive treatment for antineutrophil cytoplasmic antibody-associated vasculitis	Gulati, K; Prendecki, M; Clarke, C; Willicombe, M; McAdoo, S
Nov-2022	COVID-19 vaccine-induced antibody and T cell responses in immunosuppressed patients with inflammatory bowel disease after the third vaccine dose: a multicentre, prospective, case-control study	Alexander, J; Liu, Z; Munoz Sandoval, D; Reynolds, C; Ibraheim, H, et al